Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;18(4):857-66.
doi: 10.1007/s12253-012-9515-y. Epub 2012 Mar 24.

Revisiting CB1 receptor as drug target in human melanoma

Affiliations
Free article

Revisiting CB1 receptor as drug target in human melanoma

István Kenessey et al. Pathol Oncol Res. 2012 Oct.
Free article

Abstract

Previous studies have indicated the antitumoral effect of human melanocytes, human melanoma cell lines expressing CB1 receptor (CB1), and of the peritumoral administration of endocannabinoids. In the present study, we systematically screened several human melanoma cell lines for the expression of CNR1 and demonstrated transcription of the authentic gene. The product of CNR1, the CB1 protein, was found localized to the cell membrane as well as to the cytoskeleton. Further, the studied human melanoma cell lines expressed functional CB1 since physiological and synthetic ligands, anandamide (AEA), Met-F-AEA, ACEA and AM251 showed a wide range of biological effects in vitro, for example anti-proliferative, proapoptotic and anti-migratory. More importantly, our studies revealed that systemic administration of a stable CB1 agonist, ACEA, into SCID mice specifically inhibited liver colonization of human melanoma cells. Since therapeutic options for melanoma patients are still very limited, the endocannabinoid-CB1 receptor system may offer a novel target.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nat Med. 2002 Jun;8(6):547-50 - PubMed
    1. Int Rev Cytol. 2006;251:131-58 - PubMed
    1. J Natl Cancer Inst. 2008 Jan 2;100(1):59-69 - PubMed
    1. Cancer Res. 2001 Jan 1;61(1):303-8 - PubMed
    1. Melanoma Res. 2010 Aug;20(4):273-9 - PubMed

Publication types

MeSH terms